UMIN-CTR Clinical Trial

Unique ID issued by UMIN C000000298
Receipt number R000000382
Scientific Title Boron neutron capture therapy for high-grade glioma
Date of disclosure of the study information 2006/04/01
Last modified on 2008/06/20 15:17:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Boron neutron capture therapy for high-grade glioma

Acronym

BNCT

Scientific Title

Boron neutron capture therapy for high-grade glioma

Scientific Title:Acronym

BNCT

Region

Japan


Condition

Condition

high-grade glioma

Classification by specialty

Radiology Neurosurgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To determine safety and efficacy of BNCT

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

adverse effect

Key secondary outcomes

progression-free survival


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

intraoperative BNCT

Interventions/Control_2

external beam BNCT

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

histologic proof of WHO grade III or IV astrocytoma
KPS of 50 or more
supratentorial unilateral lesion
within 7cm from the brain surface
signed informed consent

Key exclusion criteria

seeding
abnormal data in clinical labolatory tests
double cancer
allergy for boron compounds
others

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tetsuya Yamamoto

Organization

University of Tsukuba

Division name

Department of Neurosurgery, Institute of Clinical Medicine

Zip code


Address

Tennodai 1-1-1, Tsukuba City

TEL

029-853-3220

Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

University of Tsukbua

Division name

Department of Neurosurgery, Institute of Clinical Medicine

Zip code


Address


TEL

029-853-3220

Homepage URL


Email



Sponsor or person

Institute

University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

Japan Societey for Promotion Science

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2006 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2005 Year 08 Month 01 Day

Date of IRB


Anticipated trial start date

2005 Year 08 Month 01 Day

Last follow-up date

2008 Year 12 Month 01 Day

Date of closure to data entry

2008 Year 12 Month 01 Day

Date trial data considered complete

2008 Year 12 Month 01 Day

Date analysis concluded

2009 Year 06 Month 01 Day


Other

Other related information



Management information

Registered date

2005 Year 12 Month 20 Day

Last modified on

2008 Year 06 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000382